ProstateProstate-Specific AntigenProstatic NeoplasmsProstatic HyperplasiaAndrogensReceptors, AndrogenProstatectomyAndrogen AntagonistsCell Line, TumorTransurethral Resection of ProstateOrchiectomyProstatic Intraepithelial NeoplasiaAdenocarcinomaNeoplasms, Hormone-DependentGene Expression Regulation, NeoplasticProstatic DiseasesDihydrotestosteroneTumor Markers, BiologicalTosyl CompoundsDisease ProgressionDigital Rectal ExaminationFinasterideTumor Cells, CulturedMice, NudeCell ProliferationBone NeoplasmsNeoplasm GradingAndrogen Receptor AntagonistsApoptosisProstatitisImmunohistochemistryNeoplasm MetastasisBrachytherapy5-alpha Reductase InhibitorsSeminal VesiclesAnilidesCastrationNeoplasm StagingWatchful WaitingTestosteroneFlutamideCase-Control StudiesAntineoplastic Agents, HormonalBiopsy, NeedleMetriboloneRNA, MessengerReverse Transcriptase Polymerase Chain ReactionDevice RemovalBiopsyAzasteroidsGlutamate Carboxypeptidase IISignal TransductionRisk FactorsNeoplasm TransplantationAntineoplastic AgentsNeoplasm InvasivenessTransplantation, HeterologousTime FactorsEpithelial CellsXenograft Model Antitumor Assays3-Oxo-5-alpha-Steroid 4-DehydrogenaseNeoplasm ProteinsProstatic Neoplasms, Castration-ResistantCholestenone 5 alpha-ReductaseTestosterone CongenersPrognosisBlotting, WesternPTEN PhosphohydrolaseAndrogen-Binding ProteinTreatment OutcomeGenetic Predisposition to DiseaseCell DivisionCarcinomaRadiotherapy, ConformalSensitivity and SpecificityCell Growth ProcessesProstatic Secretory ProteinsAnticarcinogenic AgentsRectumRacemases and EpimerasesGene Expression ProfilingMice, SCIDDown-RegulationCohort StudiesRadiotherapy Planning, Computer-AssistedRadiotherapy, Intensity-ModulatedEstramustineTransfectionCell SurvivalNeoplasm Recurrence, LocalAndrostenolsMass ScreeningOrgan SizeEarly Detection of CancerTaxoidsIncidenceRadiotherapy DosageProspective StudiesRNA, Small InterferingMolecular Sequence Data